US Corporate Board Director Changes SEC Filings — May 14, 2026

14-05-2026

At its 2026 Annual Meeting on May 14, 2026, Fulgent Genetics, Inc. stockholders elected Ming Hsieh, Linda Dong, Michael Nohaile, Ph.D., and Regina Groves as directors until the 2027 meeting, ratified Deloitte & Touche LLP as auditors for FY 2026, approved named executive officer compensation on an advisory basis, and approved the 2026 Equity Incentive Plan authorizing 2,000,000 new shares plus up to 1,500,000 from prior plan forfeitures. All proposals passed with a quorum of 24,578,996 shares (83% of 29,747,420 eligible), but significant opposition included 2,410,239 votes against say-on-pay and 3,513,983 against the equity plan, alongside high withheld votes for some directors (e.g., 6,015,277 for Regina Groves).

• · Proposal 1 director votes: Ming Hsieh (21,979,668 For, 276,275 Withheld); Linda Dong (16,836,781 For, 5,419,162 Withheld); Michael Nohaile (17,258,629 For, 4,997,314 Withheld); Regina Groves (16,240,666 For, 6,015,277 Withheld); all with 2,323,053 broker non-votes.
• · Proposal 2 auditor ratification: 24,470,414 For, 87,192 Against, 21,390 Abstained.
• · Proposal 3 say-on-pay: 19,800,226 For, 2,410,239 Against, 45,478 Abstained, 2,323,053 broker non-votes.
• · Proposal 4 equity plan: 18,693,758 For, 3,513,983 Against, 48,202 Abstained, 2,323,053 broker non-votes.
• · No further grants under Prior Plan after May 14, 2026; outstanding awards continue.

14-05-2026

CSX Corporation announced the immediate separation of Stephen Fortune, Executive Vice President and Chief Digital & Technology Officer, with Steve Watkins assuming his responsibilities reporting to CFO Kevin S. Boone; Fortune is eligible for severance under the CSX Executive Severance Plan. At the May 12, 2026 Annual Meeting, shareholders elected all 12 director nominees (noting significant opposition to John J. Zillmer with 299,018,366 against votes and Linda H. Riefler with 103,201,665 against), ratified Ernst & Young LLP as auditors for 2026, and approved named executive officer compensation on an advisory basis (with 98,932,409 against). The Board authorized a new $5 billion share repurchase program, providing incremental authority atop $989 million remaining as of March 31, 2026.

• · Annual Meeting held on May 12, 2026; 8-K filed May 14, 2026 with earliest event May 12, 2026.
• · Proxy Statement filed March 30, 2026 describing Executive Severance Plan.
• · Share repurchases may use open market, Rule 10b5-1 plans, accelerated repurchases, or block purchases, subject to Board discretion.

14-05-2026

Infleqtion, Inc. appointed Nicholas Johnson, 38, as a Class III director effective May 8, 2026, pursuant to Section 8.09 of the Merger Agreement with Churchill Capital Corp X, granting Churchill Sponsor X LLC the right to designate one such director. Mr. Johnson, Partner at Archimedes Advisor Group and Managing Director at M. Klein & Company (affiliate and Advisor under a $250,000 quarterly fee agreement), is not independent per NYSE standards and will not join any board committees. The appointment includes a standard indemnification agreement but no director compensation during the Advisory Agreement term, with no family relationships or other reportable related party transactions.

• · Mr. Johnson previously served as Executive Director in Investment Banking at Morgan Stanley (June 2014 to May 2021).
• · Director term expires at 2029 annual meeting of stockholders or until successor elected/qualified, death, resignation, or removal.
• · Advisory Agreement expires two years from Closing date; qualified to serve due to investing, investment banking, and public company advisory experience.
• · Previous filings: Merger Agreement (Exhibit 2.1, 8-K Feb 17, 2026), Advisory Agreement (Exhibit 10.4, same), Indemnification form (Exhibit 10.14, same), Non-Employee Director Compensation Policy (Exhibit 10.21, 10-K Dec 31, 2025).

14-05-2026

KeyCorp declared quarterly cash dividends for Q2 2026, including $0.205 per common share (NYSE: KEY) payable on June 15, 2026, and specified amounts on various preferred stock series (D through H) also payable June 15, 2026. The Board authorized a new $3.0 billion common share repurchase program, replacing the prior $1.0 billion authorization which had $280 million remaining. As of March 31, 2026, KeyCorp reported approximately $189 billion in assets, with operations in 15 states via 950 branches and 1,100 ATMs.

• · Common share dividend record date: June 2, 2026; preferred record date: June 1, 2026
• · Dividend period: March 15, 2026 to June 15, 2026 (excluding payment date)
• · Share repurchases may occur via open market, private negotiations, Rule 10b5-1 plans

14-05-2026

Joseph O. Eppers, Executive Vice President and Chief Investment Officer of Selective Insurance Group, Inc., notified the company of his retirement effective June 2, 2026, stating it is to pursue other opportunities with no disagreements on strategies, operations, policies, or practices. Vaibhav Kalia, current Senior Vice President, Senior Portfolio Manager, and Head of Fixed Income who joined in 2014, will serve as Interim Chief Investment Officer beginning on the effective date.

• · Notification provided on May 11, 2026.
• · Vaibhav Kalia joined the Company in 2014.
• · Filing signed on May 14, 2026.

14-05-2026

Kestrel Group Ltd's Compensation Committee adopted a new performance-based restricted stock agreement on May 8, 2026, granting performance awards valued at $650,000 each (61,588 shares per executive based on 20-day VWAP) on May 13, 2026, to Executive Chairman Terry Ledbetter, CEO Bradford Luke Ledbetter, and President/CFO Patrick Haveron under the 2025 Equity Incentive Plan. The awards vest in one-third increments contingent on achieving EBITDA targets for the program services segment during the FY2026 performance period (January 1 to December 31, 2026), with the first third vesting upon Committee confirmation and the remainder over two anniversaries, subject to continued employment. Provisions include forfeiture for cause or voluntary resignation, pro-rata vesting protections for death/disability/without cause terminations, and accelerated vesting in certain change-in-control scenarios.

• · Performance period: January 1, 2026 to December 31, 2026, based on EBITDA of program services segment.
• · Vesting: 1/3 upon Committee confirmation of performance goal achievement post-performance period; remaining 2/3 in equal 1/3 installments on first and second anniversaries.
• · Termination for cause or voluntary resignation (except Good Reason post-CIC): full forfeiture of unvested shares.
• · Change in control prior to vesting: performance goal deemed at greater of target or actual; full vesting if terminated without Cause or for Good Reason within 24 months post-CIC.

14-05-2026

Borealis Foods Inc. filed an 8-K on 2026-05-14 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on individuals, reasons for change, timing, or quantitative impacts are disclosed.

14-05-2026

Donnelley Financial Solutions, Inc. filed an 8-K on 2026-05-14 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details on the leadership change including key position affected, appointment or resignation status, reasons, timing, or board impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, scheduled events, or financial data are provided in the filing summary.

14-05-2026

Bruce T. Crawford resigned from Comtech Telecommunications Corp.'s Board of Directors, effective on or about June 15, 2026, to assume the role of president and Chief Executive Officer of AFCEA International. The resignation was not due to any disagreement with the Company or the Board. The Company expressed thanks for Mr. Crawford's dedication and years of service.

• · Filing Date: May 14, 2026
• · Date of earliest event reported: May 12, 2026

14-05-2026

American International Group, Inc. (AIG) announced the election of Thomas (Tom) Stoddard as an independent Director to its Board, effective June 1, 2026. Mr. Stoddard brings over 35 years of senior leadership experience in financial services, including roles as Vice Chairman of Global Investment Banking at Bank of America, Group CFO at Aviva plc and Athora Ltd., and positions at Blackstone, UBS, Credit Suisse, and Donaldson, Lufkin & Jenrette. AIG's Chairman & CEO Peter Zaffino and Lead Independent Director John Rice praised his expertise in insurance, capital markets, and corporate governance as a strong asset for the company's strategic priorities.

• · Mr. Stoddard co-founded Barrett Ellman Stoddard Capital Partners.
• · Mr. Stoddard serves on the Board of Directors of Prudential Financial, Inc.
• · Mr. Stoddard holds a bachelor’s degree in economics from Swarthmore College (McCabe Scholar) and a JD from the University of Chicago Law School.

14-05-2026

At the 2026 annual general meeting on May 14, 2026, Cushman & Wakefield Ltd. shareholders elected Jodie McLean, Timothy Wennes, and Billie Williamson to the Board for one-year terms, approved KPMG LLP as independent auditor for the year ending December 31, 2026, and approved the 2026 Omnibus Share and Cash Incentive Plan providing up to 12,150,000 plus 291,984 common shares. All proposals passed with strong majorities, including advisory approval of named executive officer compensation on an annual basis going forward. No proposals failed or faced significant opposition.

• · Proxy statement filed April 3, 2026.
• · 2026 Plan adopted by Compensation Committee on March 26, 2026, subject to shareholder approval.
• · 2026 Plan auditor appointment: 218,134,007 for, 1,923,817 against.
• · Say-on-pay: 203,900,649 for, 4,706,771 against.
• · 2026 Plan voting: 17,159,619 against, 72,337 abstain.
• · Common Shares have $0.10 par value, traded as CWK on NYSE.

14-05-2026

NeoVolta reported Q3 FY2026 revenue of $2.0 million, flat YoY at $2.0 million due to residential solar market slowdown after federal ITC expiration, while nine-month revenue grew approximately 262% to $13.3 million. Gross profit improved to $0.9 million (46% margin) from $0.5 million (26% margin), but operating expenses increased to $3.6 million from $1.9 million, resulting in a wider net loss of $3.0 million versus $1.4 million. Strategic progress included the first $1.9 million C&I purchase order from Luminia, increased ownership in NeoVolta Power to 80%, and Georgia manufacturing facility on track with equipment arrival and June 2026 installation target ahead of Q3 calendar 2026 production.

• · Luminia contracted demand of 160 MWh and active pipeline of 640 MWh, representing approximately $39 million in potential equipment revenue to NeoVolta.
• · Georgia facility designed for 2 GWh initial annual production capacity, scalable to 8 GWh.
• · Earnings conference call scheduled for May 15, 2026 at 12:00 p.m. ET.

14-05-2026

Effective May 8, 2026, Huma Qamar, M.D., MPH, CMI, separated from Ocugen, Inc. as its Chief Medical Officer. On the same date, the Company appointed Mohamed Genead, M.D., M.Sc., as Acting/Interim Chief Medical Officer. The 8-K was filed on May 14, 2026, and signed by Shankar Musunuri, Chairman, CEO, and Co-Founder.

14-05-2026

RenaissanceRe Holdings Ltd. announced that Chief Financial Officer Robert Qutub and Chief Portfolio Officer Ross Curtis intend to retire on December 31, 2026, with Matthew Neuber succeeding Qutub as CFO effective January 1, 2027, and David Marra assuming oversight of Curtis' responsibilities. The transitions highlight the company's succession planning and internal talent development, with Qutub serving as a strategic advisor for 12 months and Curtis for 6 months post-retirement. Leadership praised the contributions of retiring executives and expressed confidence in the successors' ability to drive long-term shareholder value.

• · Matthew Neuber joined RenaissanceRe in 2014 with prior experience in private equity, asset management, and investment banking focused on insurance; holds B.A. from Williams College, M.B.A. from Wharton, and CFA charterholder.
• · Robert Qutub joined in 2016 and oversaw growth including two major acquisitions and geographic expansion.
• · Ross Curtis has been with RenaissanceRe for nearly 30 years, previously Group Chief Underwriting Officer.
• · Company headquartered in Pembroke, Bermuda, established in 1993, with offices in North America, Europe, and Asia-Pacific.

14-05-2026

DMC Global Inc. held its 2026 Annual Meeting of Stockholders on May 13, 2026, electing six directors—James O'Leary, John R. Doubman, Ruth I. Dreessen, Michael A. Kelly, Ouma Sananikone, and Sharon S. Spurlin—to serve until the 2027 Annual Meeting, with vote tallies ranging from 8,794,833 to 9,789,725 For votes amid 1.9M-2.9M withheld and 6,103,673 broker non-votes. Stockholders approved the amendment and restatement of the 2025 Omnibus Incentive Plan (10,587,905 For), a non-binding say-on-pay vote (9,469,670 For vs. 1,525,877 Against), and ratified Ernst & Young LLP as auditor for FY 2026 (17,008,812 For). Of 20,475,151 shares outstanding as of the March 19, 2026 record date, 17,781,589 were present or by proxy.

• · Proposal 2 say-on-pay: 9,469,670 For, 1,525,877 Against, 682,369 Abstain
• · Proposal 3 Plan approval: 10,587,905 For, 1,065,232 Against, 24,779 Abstain
• · Proposal 4 auditor ratification: 17,008,812 For, 751,613 Against, 21,164 Abstain (no broker non-votes)
• · Definitive Proxy Statement filed March 31, 2026

14-05-2026

At the 2026 annual stockholder meeting on May 13, 2026, with 67.44% quorum of 34,618,159 eligible shares, stockholders elected Elizabeth Czerepak and John R. Sylvester as Class II directors until 2029, approved an amendment to the 2020 Omnibus Equity Incentive Plan increasing available common shares by 1,800,000 (12,770,662 For vs. 2,322,773 Against), ratified CBIZ CPAs P.C. as auditors for FY ending Dec 31, 2026, and approved named executive officer compensation on an advisory basis (13,244,653 For vs. 1,748,570 Against). All four proposals passed with majority support despite notable opposition on the equity plan and compensation.

• · Proposal 1 Director Election - Elizabeth Czerepak: 14,903,665 Votes For, 456,973 Withheld, 7,985,633 Broker Non-Votes
• · Proposal 1 Director Election - John R. Sylvester: 14,819,700 Votes For, 540,938 Withheld, 7,985,633 Broker Non-Votes
• · Proposal 2 Equity Plan Amendment: 267,202 Abstentions, 7,985,634 Broker Non-Votes
• · Proposal 3 Auditor Ratification: 22,719,287 Votes For, 191,205 Against, 435,779 Abstentions
• · Proposal 4 Say-on-Pay: 367,413 Abstentions, 7,985,635 Broker Non-Votes

14-05-2026

Alaska Silver Corp. (TSXV: WAM) announced the appointment of Aaron Schutt, President and CEO of Doyon Limited with over $500M in revenue, to its Board of Directors effective May 13, 2026, to strengthen Alaskan business connections for the Illinois Creek Project. The Company granted 1,045,609 RSUs to directors and officers, vesting in one year, and 960,000 stock options (500,000 to directors/officers) exercisable at C$0.805 for five years. CEO Kit Marrs highlighted Schutt's expertise in responsible natural resource development in Alaska.

• · Illinois Creek Project: 100%-owned, 126.4 square miles, anchored by Waterpump Creek (Inferred: 279 g/t Ag, 11.28% Zn, 9.87% Pb) and historical Illinois Creek Mine.
• · NI 43-101 Technical Report: 'Illinois Creek Project, Western Alaska, USA' dated February 25, 2026 (effective January 22, 2026).
• · Project location: 38 km from Yukon River transportation corridor.

14-05-2026

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) appointed pharma industry veteran Brent Pfeiffenberger, PharmD, MBA, currently President and CEO of Century Therapeutics (NASDAQ: IPSC), to its Board of Directors. The appointment comes ahead of key milestones, including updated Phase 1/2 data for CRB-701 at the 2026 ASCO Annual Meeting (May 29–June 2, Chicago), initiation of a registrational study for CRB-701 in second-line HNSCC this summer, and completion of the CANYON-1 Phase 1b study (n=240) for CRB-913 in summer 2026. No financial metrics or performance declines were reported.

• · FDA alignment achieved on registration path for CRB-701 in HNSCC.
• · ASCO Annual Meeting: May 29–June 2, 2026, Chicago, IL.
• · Dr. Pfeiffenberger's prior roles: COO Neogene Therapeutics (acquired by AstraZeneca 2023), SVP Head of U.S. Oncology at Bristol Myers Squibb.

14-05-2026

Following the 2026 Annual Meeting of Stockholders held on May 11, 2026, InfuSystem Holdings, Inc.'s newly constituted Board of Directors elected Beverly Huss as Chairman of the Board. There are no arrangements or understandings between Ms. Huss and any other persons pursuant to her appointment, no family relationships with the company's directors or executive officers, and no direct or indirect material interest in any disclosable transactions.

• · Event reported date: May 11, 2026
• · Filing date: May 14, 2026
• · Common Stock: par value $0.0001 per share, trading symbol INFU on NYSE American LLC

14-05-2026

Effective May 13, 2026, Timothy Weiderhoft, Chief Operating Officer of Xponential Fitness, Inc. (NYSE: XPOF), has separated from the company. The 8-K filing, dated May 14, 2026, was signed by Gavin O’Connor, Chief Legal Counsel, Chief Administrative Officer, and Secretary. No details on the reasons for departure or any successor were provided.

• · Registrant is an emerging growth company.
• · Class A Common Stock trades on New York Stock Exchange under ticker XPOF.

14-05-2026

Standex International Corporation announced the promotion of Ademir Sarcevic to Executive Vice President-Corporate and Group President-Electronics, where he will drive growth in the Electronics segment and oversee corporate projects while continuing as CFO until a successor is found. David Dunbar, President and CEO, highlighted Sarcevic's key contributions since joining as CFO in 2019, including strengthening finance, margin improvements, capital allocation, and investor relations. The move reflects the company's focus on scale, operational maturity, and growth.

• · Standex operates in four segments: Electronics, Aerospace and Defense, Scientific, Engraving & Hydraulics.
• · Operations in United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China.
• · Sarcevic joined as CFO in 2019.

14-05-2026

Effective June 1, 2026, Benoit Autier stepped down as Chief Accounting Officer of GraniteShares LLC, the sponsor of GraniteShares Platinum Trust (PLTM), with no disagreement on operations, policies, or practices. Brandon Dall’Acqua was appointed as the new Chief Accounting Officer on the same date. The change was disclosed in an 8-K filing on May 14, 2026.

• · Brandon Dall’Acqua joined GraniteShares on January 31, 2025, as Chief Financial Officer.
• · Prior to GraniteShares, Brandon Dall’Acqua was VP of Finance at Tidal Financial Group.
• · Brandon Dall’Acqua earned his Bachelors degree from Northeastern University.
• · Filing signed by William Rhind on May 14, 2026.

14-05-2026

Effective June 1, 2026, Benoit Autier stepped down as Chief Accounting Officer of GraniteShares LLC, the sponsor of GraniteShares Gold Trust (BAR), with no disagreements related to operations, policies, or practices. Brandon Dall’Acqua was appointed as the new Chief Accounting Officer on the same date. The change was disclosed in an 8-K filing on May 14, 2026.

• · Brandon Dall’Acqua joined GraniteShares on January 31, 2025, as Chief Financial Officer and previously served as VP of Finance at Tidal Financial Group.
• · Mr. Dall’Acqua earned a Bachelor's degree from Northeastern University.
• · GraniteShares Gold Trust is a New York trust with IRS Employer ID 82-6393903 and Commission File Number 333-285296.

14-05-2026

Robert Half Inc. (RHI) amended and restated its Stock Incentive Plan effective May 13, 2026, to promote long-term success, attract/retain talent, and align participants with stockholder interests through awards like Restricted Shares, Performance Shares, Stock Units, Performance Units, Options, and SARs. The plan includes detailed definitions for key terms such as Change in Control (e.g., 20% beneficial ownership threshold), performance goals (e.g., operating income, EPS), and retirement provisions (e.g., age 55+ for Staffing/Headquarters, age 60+ for Protiviti). No financial performance metrics or period-over-period changes are disclosed.

• · Filing Date: May 14, 2026
• · Effective Date: May 13, 2026
• · Performance Period: not less than one year
• · Non-Employee Director Retirement: after 7th anniversary of service or age 62
• · Protiviti Retirement: age 60+, 25 years cumulative service, 5 years with Protiviti Inc.
• · Staffing/Headquarters Retirement: age 55+ or 20 years service